Stock comparison

ABBVvsNTRA

AbbVie IncvsNatera Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

ABBV

AbbVie Inc

$200.95

-12.05%

Biotechnology$362.8BNYSE

NTRA

Natera Inc

$201.14

-11.94%

Biotechnology$28.0BNASDAQ

60-day price, rebased to 100

ABBV -8.25% · NTRA -13.11%

Round-by-round

ABBV 4·NTRA 1· 1tie

EdgeABBV

Valuation upside

-48.60% vs -67.20% to DCF fair value

EdgeNTRA

Balance-sheet strength

Altman Z 2.25 vs 23.91

EdgeABBV

Fundamental quality

Piotroski 7.00 vs 5.00 (of 9)

Tie

Growth + margins

Rule-of-40 37.70 vs 39.20

EdgeABBV

60-day momentum

-8.25% vs -13.11% price return

EdgeABBV

Market-cap liquidity

$362.8B vs $28.0B

Verdict

Across6categories,ABBVtakes the edge with4wins to1 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onABBVorNTRA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.